Blood-Based Biomarkers for Alzheimer Disease
This Viewpoint discusses areas of potential harm and actions needed to mitigate risk so that the use of blood-based biomarkers for Alzheimer disease can achieve the intended goal of improving care for all.
Authors
- Heather Elizabeth Whitson (ORCID: https://orcid.org/0000-0002-8417-4846)
- Nicole R. Fowler
- Michelle M. Mielke
Institutions
- Regenstrief Institute (US)
- Duke University (US)
- Duke Energy (United States) (US)
- Durham VA Medical Center (US)
- Indiana University School of Medicine
- Wake Forest University (US)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- JAMA
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1001/jama.2025.26049
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00